June 11, 2021 ~ MedPage Today ~ by Mike Bassett
Cancer Patients See High Seroconversion Rates After COVID Vax
— Dampened responses seen in those with hematological malignancies, however
Patients with cancer who were vaccinated against COVID-19 achieved high seroconversion rates, a single-center study found.
The rate of seroconversion was especially high among patients with solid tumors (98%). However, patients with hematological malignancies achieved lower rates (85%), particularly those who had undergone highly immunosuppressive therapies, reported Balazs Halmos, MD, MS, of Montefiore Medical Center in New York City, and colleagues.
Patients with hematological malignancies also showed significantly lower titer levels compared to solid tumor patients and non-cancer controls, according to the findings in Cancer Cell.